Paul J. Clancy, CFO at BIOGEN IDEC INC. (BIIB), sold 4,208 shares at $56.01 ($236K) on 2008-07-01, disclosed to the SEC on 2008-07-02.
Scheduled sale ($236k) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ALXN | SELL | 2018-02-08 | $1.4M | — | Filing → |
| BIIB | SELL | 2017-04-27 | $2.9M | — | Filing → |
| BIIB | SELL | 2017-03-14 | $5.8M | — | Filing → |